For today's technical update and virtual media briefing on ACT-Accelerator, please find the planned detailed agenda below.
Subject: ACT-Accelerator – Technical Update and Press Briefing
TIME: Please note that the event will begin today Friday 26 June at 1400 CEST with a technical briefing, which journalists are welcome to join.
A virtual media briefing will be held following the technical briefing. This replaces our normally scheduled (1700 CEST) COVID-19 virtual press conference for today only.
The technical briefing will be moderated by Dr Bruce Aylward, WHO Senior Adviser and Head of the ACT-Accelerator Coordination Hub.
Opening: Dr Tedros Adhanom Ghebreyesus, Director-General, WHO
Overview of ACT-Accelerator from Envoys: Sir Andrew Witty, Special Envoy for the ACT-Accelerator
The 4 pillars:
- Diagnostics: FIND and Global Fund. Dr Peter Sands, Executive Director, The Global Fund to Fight AIDS, Tuberculosis and Malaria
- Therapeutics: Wellcome and Unitaid. Dr Philippe Duneton, Executive Director ad interim, Unitaid
- Vaccines: CEPI, GAVI and WHO. Dr Soumya Swaminathan, Chief Scientist, WHO
- Health Systems Connector: World Bank & Global Fund. Dr. Muhammad Pate, Global Director for Health, Nutrition and Population, World Bank Group
The equitable allocation framework: Dr Mariangela Simao, Assistant Director General for Access to Medicines, Vaccines and Pharmaceuticals, WHO
Why this is urgent and the funding shortfall: Dr Ngozi Okonjo-Iweala, Special Envoy for the ACT-Accelerator
Press questions (30 mins) - facilitated by Ms Fadéla Chaib, WHO
Dr Tedros Adhanom Ghebreyesus, Director-General, WHO
Sir Andrew Witty, Director-General Special Envoy for the ACT-Accelerator
Dr Ngozi Okonjo-Iweala, Director-General Special Envoy for the ACT-Accelerator
Dr Peter Sands, Executive Director, The Global Fund to Fight AIDS, Tuberculosis and Malaria
Dr Philippe Duneton, Executive Director ad interim, Unitaid
Dr Soumya Swaminathan, Chief Scientist, WHO
Dr Mariangela Simao, Assistant Director General for Access to Medicines, Vaccines and Pharmaceuticals, WHO
Dr Muhammad Pate, Global Director for Health, Nutrition and Population, World Bank
Switzerland: +41 22 591 00 05
US: +1 720 928 9299
United Kingdom: +44 330 088 5830
France: +33 1 7037 2246 or +33 1 7037 9729 or +33 1 7095 0103 or +33 1 7095 0350 or +33 7 5678 4048
Webinar ID: 926 3767 3165
International numbers available: https://who.zoom.us/u/aeBKqBkDP6
Please ensure you enter your name and media outlet (use name/outlet) We are now using a waiting room prior to the meeting commencing; when you sign in you will be automatically put in the meeting room.
Kindly note, only questions from media (one per journalist) will be allowed during the press conference. In addition, if the capacity of the room is reached, individuals who are not named correctly might need to make room for registered journalists. Therefore, please ensure that you are named correctly with your name and media outlet.
To ask a question, please click "raise hand" and this will enter you into the queue for questions. (it can be found under the tab: participants)
Please make sure you have a microphone connected or active on your computer. Please do not ask questions via the chat as we can not guarantee that we will see them and be able to incorporate them into the Q&A session.
Interpretation will be provided in the six UN languages. Choices are under "interpretation" or "language interpretation" depending on which version of Zoom application you are using.
WHO Media Team